La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

IHH Healthcare Berhad Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Prem Kumar Nair

Directeur général

n/a

Rémunération totale

Pourcentage du salaire du PDG	n/a
Durée du mandat du directeur général	less than a year
Propriété du PDG	n/a
Durée moyenne d'occupation des postes de direction	2.8yrs
Durée moyenne du mandat des membres du conseil d'administration	1.5yrs

Mises à jour récentes de la gestion

Recent updates

PDG

Prem Kumar Nair (63 yo)

less than a year

Titularisation

Dr. Prem Kumar Nair serves as Non-Executive Director of Parkway Trust Management Limited a Manager of Parkway Life Real Estate Investment Trust since November 17, 2023. He serves as Vice Chairman of the Bo...

Équipe de direction

Nom	Position	Titularisation	Compensation	Propriété
Prem Kumar Nair	Group Chief Executive Officer	less than a year	pas de données	pas de données
Dilip Kadambi	Group Chief Financial Officer	less than a year	pas de données	pas de données
Penelope Koh	Vice President of Investor Relations	no data	pas de données	pas de données
Nili Shayrina Saat	Group Head of Risk Management & Compliance	1.6yrs	pas de données	pas de données
Ida binti Ab Rahim	Group General Counsel & Company Secretary	5.2yrs	pas de données	pas de données
Stephen Byrne	Group Head of Internal Audit	3.6yrs	pas de données	pas de données
Ashok Pandit	Group Chief Corporate Officer	3yrs	pas de données	pas de données
Jean-Francois Naa	Chief Executive Officer of HH Healthcare Malaysia	4.4yrs	pas de données	pas de données
Zhiping Li	Chief Executive Officer of IHH Healthcare China	3.8yrs	pas de données	pas de données
Anurag Yadav	Chief Executive Officer of IHH Healthcare India	2.6yrs	pas de données	pas de données
Chorng Ann Chow	Chief Executive Officer of IHH Healthcare Singapore	less than a year	pas de données	pas de données
Kenneth Tsang	Regional Chief Executive Officer of IHH Healthcare North Asia	no data	pas de données	pas de données

2.8yrs

Durée moyenne de l'emploi

53.5yo

Âge moyen

Gestion expérimentée: L'équipe de direction de Q0F est considérée comme expérimentée (ancienneté moyenne 2.8 ans).

Membres du conseil d'administration

Nom	Position	Titularisation	Compensation	Propriété
Yoichiro Endo	Non-Independent Non-Executive Director	less than a year	pas de données	pas de données
Nik Norzrul Bin Nik Hassan Thani	Independent Non-Executive Chairman	less than a year	pas de données	pas de données
Muthanna Bin Abdullah	Independent Non-Executive Director	no data	RM 660.00k	pas de données
Satoshi Tanaka	Independent Non-Executive Director	no data	RM 485.00k	pas de données
Mehmet Aydinlar	Non-Independent & Non-Executive Director	12.6yrs	RM 385.00k	0.17% MYR 28.3m
Jill Watts	Independent Non-Executive Director	no data	RM 660.00k	pas de données
Mohd Bin Mohd Harris	Non-Independent & Non-Executive Director	1.4yrs	pas de données	pas de données
Tomo Nagahiro	Non-Independent & Non-Executive Director	1.5yrs	pas de données	pas de données
Tsin-Lin Lim	Non Independent Non Executive Director	1.5yrs	pas de données	pas de données
Jia Mok	Non Independent & Non Executive Alternate Director	1.5yrs	pas de données	pas de données

1.5yrs

Durée moyenne de l'emploi

61yo

Âge moyen

Conseil d'administration expérimenté: Les membres du conseil d'administration de Q0F ne sont pas considérés comme expérimentés (ancienneté moyenne 1.5 ans), ce qui suggère un nouveau conseil d'administration.

IHH Healthcare Berhad Gestion

Gestion contrôle des critères 1/4

Informations clés

Mises à jour récentes de la gestion

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

High number of new directors

Recent updates

First half dividend of RM0.045 announced

IHH Healthcare Berhad Declares Interim Single Tier Cash Dividend for the Financial Year Ending 31 December 2024, Payable on October 30, 2024

Second quarter 2024 earnings released: EPS: RM0.071 (vs RM0.034 in 2Q 2023)

IHH Healthcare Berhad Announces Resignation of Mohd Shahazwan Bin Mohd Harris as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces the Appointment of Chua Bin Hwee as Independent and Non Executive Director, Effective August 14, 2024

IHH Healthcare Berhad to Report Q2, 2024 Results on Aug 30, 2024

IHH Healthcare Berhad Appoints Tan Sri Dr. Nik Norzrul Thani Bin N. Hassan Thani as Independent and Non Executive Chairman

New minor risk - Earnings quality

First quarter 2024 earnings released: EPS: RM0.087 (vs RM0.16 in 1Q 2023)

IHH Healthcare Berhad Announces Retirement of Miss Ong Ai Lin as Independent and Non Executive Member of Risk Committee

IHH Healthcare Berhad Announces Retirement of Ong Ai Lin as Chairman of Audit Committee Independent and Non Executive, Effective 28 May 2024

IHH Healthcare Berhad to Report Q1, 2024 Results on May 29, 2024

High number of new directors

IHH Healthcare Berhad, Annual General Meeting, May 28, 2024

IHH Healthcare Berhad Appoints Dilip Kadambi as Group Chief Financial Officer

Ihh Healthcare Berhad Announces Resignation of Takeshi Akutsu as Non Independent and Non Executive Director, Effective March 31, 2024

Upcoming dividend of RM0.055 per share

Dividend of RM0.055 announced

Full year 2023 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad to Report Q4, 2023 Results on Feb 29, 2024

IHH Healthcare Berhad Announces Cessation of Joerg Ayrle as Chief Financial Officer

Third quarter 2023 earnings released: EPS: RM0.06 (vs RM0.028 in 3Q 2022)

IHH Healthcare Berhad to Report Q3, 2023 Results on Nov 30, 2023

IHH Healthcare Berhad Announces Joerg Ayrle, Group Chief Financial Officer to Remain on Garden Leave, Effective from 30 September 2023

Upcoming dividend of RM0.035 per share at 1.2% yield

IHH Healthcare Berhad Declares Interim Dividend, Payable on October 27, 2023

Second quarter 2023 earnings released: EPS: RM0.034 (vs RM0.067 in 2Q 2022)

IHH Healthcare Berhad to Report Q2, 2023 Results on Aug 29, 2023

First quarter 2023 earnings released: EPS: RM0.16 (vs RM0.054 in 1Q 2022)

Upcoming dividend of RM0.096 per share at 1.2% yield

IHH Healthcare Berhad to Report Q1, 2023 Results on May 31, 2023

IHH Healthcare Berhad Announces Special Cash Dividend, Payable on 30 June 2023

High number of new directors

Upcoming dividend of RM0.07 per share at 1.2% yield

Full year 2022 earnings released: EPS: RM0.17 (vs RM0.20 in FY 2021)

IHH Healthcare Berhad Announces Appointment of Mr. Takeshi Akutsu as Non Independent and Non Executive Member of Nomination and Remuneration Committee

IHH Healthcare Berhad Announces Resignation of Farid Bin Mohamed Sani as Non Independent and Non Executive Director

IHH Healthcare Berhad Appoints Tomo Nagahiro as Non-Independent and Non-Executive Director

IHH Healthcare Berhad to Report Q4, 2022 Results on Feb 28, 2023

IHH Healthcare Berhad Announces the Resignation of Tomo Nagahiro as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad Announces the Cessation of Takeshi Saito as Member of Nomination and Remuneration Committee, Effective January 27, 2023

Third quarter 2022 earnings released: EPS: RM0.028 (vs RM0.06 in 3Q 2021)

IHH Healthcare Berhad to Report Q3, 2022 Results on Nov 29, 2022

United States Federal District Court Grants IHH Healthcare Berhad Motion to Dismiss Emqore Amended Complaint

Second quarter 2022 earnings released: EPS: RM0.067 (vs RM0.053 in 2Q 2021)

IHH Healthcare Berhad Reports Write Offs for the Second Quarter Ended June 30, 2022

IHH Healthcare Berhad to Report Q2, 2022 Results on Aug 25, 2022

TPG Capital, L.P. and Hong Leong Group Malaysia agreed to acquire 100% of IMU Health Sdn Bhd from IHH Healthcare Berhad (KLSE:IHH) for a total enterprise value of MYR 1345 million.

TPG Capital, L.P. and Hong Leong Group Malaysia agreed to acquire 100% of IMU Health Sdn Bhd from IHH Healthcare Berhad (KLSE:IHH) for MYR 1345 million.

First quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

IHH Healthcare Berhad to Report Q1, 2022 Results on May 26, 2022

Now 20% undervalued

High number of new directors

Now 22% undervalued after recent price drop

Permodalan Nasional Reportedly Looking to Dispose of A Portion of Its Shares in IHH Healthcare and Petronas Chemicals Group

IHH Healthcare Berhad Provides Update on Material Litigation

Upcoming dividend of RM0.06 per share

Full year 2021 earnings: EPS and revenues exceed analyst expectations

IHH Healthcare Berhad Reports Impairment for the Fourth Quarter Ended December 31, 2021

IHH Healthcare Berhad Announces the Resignation of Wong Eugene as Non Independent and Non Executive Alternate Director

IHH Healthcare Berhad to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Now 22% undervalued after recent price drop

Fortis Healthcare Limited Updates on Its Complaint

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

Second quarter 2021 earnings released: EPS RM0.053 (vs RM0.016 loss in 2Q 2020)

First quarter 2021 earnings released: EPS RM0.04 (vs RM0.039 loss in 1Q 2020)

Independent Non-Executive Director has left the company